Details of the Drug
General Information of Drug (ID: DMNRWEV)
Drug Name |
5-{8(Z),-pentadecenyl}resorcinol
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Bilobol; 5-[(8Z)-pentadec-8-en-1-yl]benzene-1,3-diol; 5-[(8Z)-pentadec-8-enyl]resorcinol; CHEBI:3104; CHEMBL461628; 5-(8Z-Pentadecenyl)resorcinol; 22910-86-7; 5-[(Z)-pentadec-8-enyl]benzene-1,3-diol; (Z)-5-(Pentadec-8-en-1-yl)benzene-1,3-diol; Trifurcatol A2; Cardol monoene; 5-{8(Z),-pentadecenyl}resorcinol; Bilobol C15:1; AC1NQZ6L; 21:1-.omega.7-Cardol; SCHEMBL164545; 5-(8'Z-heptadecenyl)resorcinol; DTXSID90872874; TUGAUFMQYWZJAB-FPLPWBNLSA-N; MolPort-005-945-917; ZINC8234356; 5-[8'(Z)-Pentadecenyl]Resorcinol
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 2 | Molecular Weight (mw) | 318.5 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 8.1 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 13 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||